- ACP's guidance addresses cannabis or cannabinoid use for chronic noncancer pain counseling.
- Evidence has revealed modest effectiveness of cannabinoid formulations.
- Counsel patients about benefits and harms when they consider starting or continuing cannabis or cannabinoids for chronic noncancer pain.
- Specific patient subgroups should be advised against cannabis use due to potential harms, such as young adults and adolescents, patients with current or past substance use disorder, those with serious mental illness, and frail patients at risk for falling.
- Clinicians should advise against cannabis use in pregnant or breastfeeding patients or those trying to conceive.
- Inhaled cannabis for pain management should not be recommended.
Source: Annals of Internal Medicine
